The ratio of intratumour to stromal infiltrating lymphocytes better predicts prognosis in breast cancer

Clin Transl Med. 2023 May;13(5):e1265. doi: 10.1002/ctm2.1265.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't
  • Research Support, N.I.H., Extramural

MeSH terms

  • Breast Neoplasms* / diagnosis
  • Breast Neoplasms* / pathology
  • Female
  • Humans
  • Lymphocytes
  • Lymphocytes, Tumor-Infiltrating
  • Prognosis